New lotion for Kids' psoriasis shows promise in small safety study

NCT ID NCT03988439

First seen Apr 24, 2026 ยท Last updated Apr 24, 2026

Summary

This study looked at how a medicated lotion (IDP-118) is absorbed through the skin in children aged 4 to 16 with moderate to severe plaque psoriasis. Researchers measured drug levels in the blood and checked if the lotion affected the adrenal glands, which control stress hormones. The goal was to understand safety and how the body processes the medication.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary โ€” we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PSORIASIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • Bausch Site 1

    Henderson, Nevada, 89052, United States

  • Bausch Site 11

    Miami, Florida, 33173, United States

  • Bausch Site 12

    Santo Domingo, Dominican Republic

  • Bausch Site 2

    Panama City, Panama

  • Bausch Site 3

    Louisville, Kentucky, 40217, United States

  • Bausch Site 4

    Murray, Utah, 84123, United States

  • Bausch Site 5

    San Antonio, Texas, 78213, United States

  • Bausch Site 6

    Saint Joseph, Missouri, 64506, United States

  • Bausch Site 7

    Doral, Florida, 33166, United States

Conditions

Explore the condition pages connected to this study.